Lifecore Biomedical (LFCR) News Today $6.48 +0.04 (+0.62%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Lifecore Biomedical, Inc. (NASDAQ:LFCR) Short Interest UpdateJanuary 20 at 1:44 AM | americanbankingnews.comShort Interest in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Increases By 6.4%Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 2,500,000 shares, an increase of 6.4% from the December 15th total of 2,350,000 shares. Based on an average daily trading volume, of 240,000 shares, the short-interest ratio is presently 10.4 days. Currently, 7.6% of the shares of the company are sold short.January 19 at 6:37 AM | marketbeat.comLifecore Biomedical Announces Special Stockholder MeetingJanuary 17 at 5:24 PM | globenewswire.comFY2025 EPS Estimates for LFCR Boosted by Barrington ResearchJanuary 12, 2025 | americanbankingnews.comResearch Analysts Offer Predictions for LFCR FY2025 EarningsLifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Research analysts at Barrington Research increased their FY2025 earnings per share (EPS) estimates for Lifecore Biomedical in a note issued to investors on Wednesday, January 8th. Barrington Research analyst M. Petusky now anticipates that tJanuary 10, 2025 | marketbeat.comLifecore Biomedical’s Strategic Asset Sale Supports Hold Rating Amid Leverage ConcernsJanuary 9, 2025 | markets.businessinsider.comLifecore Biomedical, Inc.: Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 MillionJanuary 8, 2025 | finanznachrichten.deLifecore Biomedical, Inc. (NASDAQ:LFCR) CEO Paul Josephs Acquires 17,000 SharesLifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) CEO Paul Josephs acquired 17,000 shares of the business's stock in a transaction that occurred on Wednesday, January 8th. The shares were acquired at an average cost of $5.74 per share, with a total value of $97,580.00. Following the completion of the transaction, the chief executive officer now directly owns 559,717 shares in the company, valued at approximately $3,212,775.58. The trade was a 3.13 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.January 8, 2025 | marketbeat.comLifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 MillionJanuary 7, 2025 | globenewswire.comLifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | globenewswire.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call TranscriptJanuary 4, 2025 | insidermonkey.comStocks to Watch: Lifecore Biomedical, Resources ConnectionJanuary 4, 2025 | marketwatch.comBarrington Keeps Their Hold Rating on Lifecore Biomedical (LFCR)January 4, 2025 | markets.businessinsider.comLifecore Biomedical's (LFCR) "Equal Weight" Rating Reaffirmed at StephensStephens reiterated an "equal weight" rating and set a $6.00 price objective on shares of Lifecore Biomedical in a report on Friday.January 3, 2025 | marketbeat.comLifecore Biomedical, Inc.: Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateJanuary 3, 2025 | finanznachrichten.deLifecore Biomedical reports Q2 EPS (25c), two estimates (31c)January 3, 2025 | markets.businessinsider.comLifecore Biomedical (NASDAQ:LFCR) Stock Quotes, Forecast and News SummaryJanuary 3, 2025 | benzinga.comLifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue EstimatesJanuary 3, 2025 | msn.comLifecore Biomedical Reports Q2 Fiscal 2025 ResultsJanuary 2, 2025 | tipranks.comLifecore Biomedical, Inc. (LFCR) Q2 2025 Earnings Call TranscriptJanuary 2, 2025 | seekingalpha.comLifecore Biomedical Swings to 2Q Loss Despite Higher SalesJanuary 2, 2025 | marketwatch.comLifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPSLifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its earnings results on Thursday. The company reported ($0.25) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.02. Lifecore Biomedical had a negative return on equity of 382.65% and a net margin of 5.09%.January 2, 2025 | marketbeat.comLifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateJanuary 2, 2025 | globenewswire.comIs Now The Time To Look At Buying Lifecore Biomedical, Inc. (NASDAQ:LFCR)?December 30, 2024 | uk.finance.yahoo.comLifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025December 19, 2024 | globenewswire.comLifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder TreatmentDecember 19, 2024 | globenewswire.com272 Capital LP Acquires 120,002 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR)272 Capital LP boosted its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 511.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 143,480 shares of the company's stock after purchasing anDecember 13, 2024 | marketbeat.comHere’s Why Arquitos Capital Management Largely Exited Lifecore (LFCR)December 12, 2024 | msn.comLifecore Biomedical (NASDAQ:LFCR) investors are sitting on a loss of 33% if they invested five years agoDecember 3, 2024 | finance.yahoo.comCraig-Hallum Reaffirms Their Buy Rating on Lifecore Biomedical (LFCR)November 27, 2024 | markets.businessinsider.comLifecore Biomedical Strengthens Financial Position with Key MovesNovember 27, 2024 | markets.businessinsider.comLifecore Biomedical Amends and Extends Revolving Credit Facility with BMONovember 26, 2024 | globenewswire.comLifecore Biomedical shares target upgraded, keeps buy on growth prospectsNovember 24, 2024 | uk.investing.comCraig-Hallum Remains a Buy on Lifecore Biomedical (LFCR)November 23, 2024 | markets.businessinsider.comBarrington Remains a Hold on Lifecore Biomedical (LFCR)November 23, 2024 | markets.businessinsider.comCraig Hallum Boosts Lifecore Biomedical (NASDAQ:LFCR) Price Target to $10.00Craig Hallum increased their target price on Lifecore Biomedical from $8.00 to $10.00 and gave the stock a "buy" rating in a research note on Friday.November 22, 2024 | marketbeat.comLifecore Biomedical Plans Strategic Growth and TransformationNovember 21, 2024 | markets.businessinsider.comLifecore Biomedical Hosts Virtual Investor DayNovember 21, 2024 | globenewswire.comLifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge fundsNovember 13, 2024 | finance.yahoo.comLifecore Biomedical to Present at Stephens Annual Investment ConferenceNovember 12, 2024 | globenewswire.comLifecore Biomedical: Finally A 'Pure Play' CDMO BusinessNovember 12, 2024 | seekingalpha.comLifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024November 7, 2024 | globenewswire.comLifecore Biomedical (NASDAQ:LFCR) Stock Price Up 4.5% - Here's WhyLifecore Biomedical (NASDAQ:LFCR) Trading 4.5% Higher - What's Next?November 7, 2024 | marketbeat.comLifecore appoints Guldager as vice president, operationsNovember 5, 2024 | markets.businessinsider.comLifecore Biomedical Appoints Thomas Guldager as Vice President, OperationsNovember 4, 2024 | globenewswire.comChaska’s Lifecore looks to growth in coming years after emerging from delisting challengeNovember 1, 2024 | startribune.comJohnson Fistel LLP Investigates Lifecore Biomedical, Inc's Directors and Officers for Breach of Fiduciary Duties and Encourages Long Term Shareholders to Reach Out for Their OptionsOctober 11, 2024 | globenewswire.comQ3 2025 EPS Estimates for Lifecore Biomedical, Inc. (NASDAQ:LFCR) Lifted by Barrington ResearchLifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Analysts at Barrington Research boosted their Q3 2025 earnings estimates for shares of Lifecore Biomedical in a research report issued on Monday, October 7th. Barrington Research analyst M. Petusky now anticipates that the company will postOctober 9, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR)Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Equities research analysts at Barrington Research issued their Q1 2026 EPS estimates for shares of Lifecore Biomedical in a note issued to investors on Monday, October 7th. Barrington Research analyst M. Petusky forecasts that the company wiOctober 8, 2024 | marketbeat.comLifecore Biomedical: A Cautious Hold Amid Modest Growth and Financial ChallengesOctober 8, 2024 | markets.businessinsider.com Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address LFCR Media Mentions By Week LFCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFCR News Sentiment▼0.560.44▲Average Medical News Sentiment LFCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFCR Articles This Week▼35▲LFCR Articles Average Week Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Gyre Therapeutics News Today Poseida Therapeutics News Today Oculis News Today Nuvation Bio News Today Anavex Life Sciences News Today AbCellera Biologics News Today CureVac News Today ArriVent BioPharma News Today Cogent Biosciences News Today Phibro Animal Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFCR) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
